Open AccessClinical Scores Evaluation for Brazilian CRS Patients
Author(s) -
Tamashiro Edwin,
Adelino Odair Aparecido,
Valera Fabiana C. P.,
Antunes Marcelo Barros,
AnselmoLima Wilma T.
Publication year - 2011
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599811415823a391
Subject(s) - medicine , endoscopy , radiology
Objective Evaluate if the clinical measures SNOT‐22 and UPSIT are efficient in monitoring treatment in Brazilian patients with CRS. Method A total of 16 patients with CRS were treated with topical mometasone (200 microgram BID) for 2 months. SNOT‐22, sense of smell score in SNOT‐22, UPSIT, Lund‐Mackay (for CT) and Lund (for endoscopy) scores were evaluated before and after treatment. Multi‐variable correlation tests were used to compare the differences between scales. Results Improvement in UPSIT scores correlated negatively to the sense of smell score in SNOT‐22, (R2: 0.50; P =. 0367), demonstrating to be a good tool to quantify smell problems. On the contrary, UPSIT did not correlate with CT and endoscopy scores. Improvement in SNOT‐22 scores correlated significantly to improvement in endoscopy scores (R2: 0.49; P =. 0297), but not to CT and UPSIT scores. Conclusion UPSIT is a valuable tool to measure smell changes and monitor the effect of clinical treatment in patients with CRS. SNOT‐22 correlated positively to intranasal polyp formation rather than sinusal opacity on CT scans.